Skip to Content

APO IMA 400 (Imatinib Mesylate 400 mg)

Pill with imprint APO IMA 400 is Orange, Capsule-shape and has been identified as Imatinib Mesylate 400 mg. It is supplied by Apotex Corp..

Imatinib is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO IMA 400

Imatinib mesylate 400 mg APO IMA 400
Imatinib mesylate 400 mg APO IMA 400
Imatinib mesylate 400 mg APO IMA 400

Imatinib Mesylate

Imprint
APO IMA 400
Strength
400 mg
Color
Orange
Size
17.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
Inactive Ingredients
silicon dioxide, crospovidone, magnesium stearate, hypromellose 2910 (5 mPa.s), hydroxypropyl cellulose (type l), ferric oxide red, ferric oxide yellow, polyethylene glycol 8000

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
60505-2901 Apotex Corp.
42291-0352 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.